Abstract
A higher intake of total sugar was associated with increased odds of clinically relevant depressive symptoms among obese adults. Further studies are necessary to confirm the role of total sugar in depressive symptoms among obese adults.
Introduction
While previous research has frequently linked sugar-sweetened beverages (SSBs) to depression, the impact of total dietary sugar—including sugar from solid foods—is less understood. Furthermore, obesity and depression often share a bidirectional relationship, yet few studies have investigated whether the association between sugar and mood varies across different Body Mass Index (BMI) categories. This study sought to determine if total sugar consumption is a universal risk factor for depressive symptoms or if its effects are amplified in the context of obesity, where metabolic and inflammatory pathways are already altered.
Methods
The researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES) spanning 2011 to 2018, resulting in a final analytical sample of 16,009 adults.
- Dietary Assessment: Total sugar intake was calculated using the average of two 24-hour dietary recalls. Participants were divided into quintiles (Levels 1-5) based on their intake.
- Mental Health Assessment: Depressive symptoms were measured using the PHQ-9 (Patient Health Questionnaire-9), with a score of $\ge$ 10 used as the threshold for "clinically relevant" symptoms.
- Statistical Modeling: Multivariable logistic regression models adjusted for a wide array of confounders including age, gender, energy intake, physical activity, and comorbidities like hypertension and diabetes.
- Stratification: The population was stratified into three groups: normal weight (BMI < 25), overweight (25 $\le$ BMI < 30), and obese (BMI $\ge$ 30).
Results
Dose-Response and Linearity
Using Restricted Cubic Spline (RCS) models, the authors found a linear dose-response relationship in the general population. There was no specific "safe" threshold; instead, as sugar intake increased, the odds of depressive symptoms rose steadily.
Association in the General Population
In the overall population, after full adjustment for confounders (Adjusted Model 2), individuals in the highest quintile of sugar intake had 1.56 times the odds (95% CI: 1.18–2.05) of experiencing depressive symptoms compared to those in the lowest quintile.
The "Obesity Interaction"
A key finding of this study is that the sugar-depression link is not uniform across BMI categories. When stratified, the association remained robust for obese adults ($P$ for trend = 0.013) but was not statistically significant for those in the normal or overweight categories ($P$ for trend = 0.065 and 0.193, respectively). This suggests that the physiological environment of obesity might make the brain more vulnerable to the effects of high sugar intake.
Discussion and Limitations
The authors hypothesize that sugar intake may trigger or exacerbate neuroinflammation, insulin resistance in the brain, and dysregulation of the Hypothalamic-Pituitary-Adrenal (HPA) axis—pathways already implicated in the pathology of both obesity and depression.
However, as a cross-sectional study, this research cannot prove causality. It is possible that depressed individuals with obesity engage in "emotional eating," leading to higher sugar consumption. Furthermore, both dietary recalls and the PHQ-9 rely on self-reporting, which can introduce recall bias. The PHQ-9 is a screening tool for symptoms, not a formal clinical diagnosis of Major Depressive Disorder.
Conclusion
Total sugar intake is significantly associated with increased odds of depressive symptoms, specifically among obese adults. Future longitudinal studies and randomized controlled trials are necessary to establish temporal order and determine if reducing sugar intake can serve as an effective intervention for improving mood in patients with obesity.
Summary updated